KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 71 filers reported holding KRONOS BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $231,791 | -24.4% | 178,301 | 0.0% | 0.00% | – |
| Q2 2023 | $306,678 | -73.0% | 178,301 | -77.1% | 0.00% | – |
| Q1 2023 | $1,137,928 | -52.0% | 779,403 | -46.7% | 0.00% | – |
| Q4 2022 | $2,368,478 | -3.8% | 1,462,024 | +98.9% | 0.00% | – |
| Q3 2022 | $2,463,000 | -6.0% | 735,099 | +2.2% | 0.00% | – |
| Q2 2022 | $2,619,000 | -81.2% | 719,529 | -62.6% | 0.00% | -100.0% |
| Q1 2022 | $13,928,000 | -30.5% | 1,926,399 | +30.5% | 0.00% | 0.0% |
| Q4 2021 | $20,054,000 | +46.7% | 1,475,619 | +126.3% | 0.00% | 0.0% |
| Q3 2021 | $13,667,000 | +5.1% | 652,030 | +20.1% | 0.00% | 0.0% |
| Q2 2021 | $13,006,000 | +98.2% | 543,044 | +142.2% | 0.00% | – |
| Q1 2021 | $6,562,000 | -2.2% | 224,205 | -0.2% | 0.00% | – |
| Q4 2020 | $6,709,000 | – | 224,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $19,993,000 | 11.63% |
| Omega Fund Management, LLC | 3,818,283 | $27,606,000 | 5.65% |
| Nextech Invest Ltd. | 1,451,537 | $10,495,000 | 3.00% |
| Wildcat Capital Management, LLC | 1,438,232 | $10,398,000 | 2.66% |
| Artal Group S.A. | 1,542,954 | $11,156,000 | 0.47% |
| Perceptive Advisors | 2,421,142 | $17,504,000 | 0.35% |
| Alphabet Inc. | 1,438,232 | $10,398,000 | 0.34% |
| Casdin Capital, LLC | 583,436 | $4,218,000 | 0.19% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $3,814,000 | 0.19% |
| Samsara BioCapital, LLC | 78,131 | $565,000 | 0.14% |